BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29459625)

  • 1. Molecular subtypes of Alzheimer's disease.
    Di Fede G; Catania M; Maderna E; Ghidoni R; Benussi L; Tonoli E; Giaccone G; Moda F; Paterlini A; Campagnani I; Sorrentino S; Colombo L; Kubis A; Bistaffa E; Ghetti B; Tagliavini F
    Sci Rep; 2018 Feb; 8(1):3269. PubMed ID: 29459625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease.
    Rasmussen J; Mahler J; Beschorner N; Kaeser SA; Häsler LM; Baumann F; Nyström S; Portelius E; Blennow K; Lashley T; Fox NC; Sepulveda-Falla D; Glatzel M; Oblak AL; Ghetti B; Nilsson KPR; Hammarström P; Staufenbiel M; Walker LC; Jucker M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13018-13023. PubMed ID: 29158413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
    Kumar S; Lemere CA; Walter J
    Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
    Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
    Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Tanaka M; Saito S; Inoue T; Satoh-Asahara N; Ihara M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.
    Jaunmuktane Z; Mead S; Ellis M; Wadsworth JD; Nicoll AJ; Kenny J; Launchbury F; Linehan J; Richard-Loendt A; Walker AS; Rudge P; Collinge J; Brandner S
    Nature; 2015 Sep; 525(7568):247-50. PubMed ID: 26354483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.
    Kane MD; Lipinski WJ; Callahan MJ; Bian F; Durham RA; Schwarz RD; Roher AE; Walker LC
    J Neurosci; 2000 May; 20(10):3606-11. PubMed ID: 10804202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
    Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
    Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.
    Walker LC; Schelle J; Jucker M
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.
    Kumar S; Rezaei-Ghaleh N; Terwel D; Thal DR; Richard M; Hoch M; Mc Donald JM; Wüllner U; Glebov K; Heneka MT; Walsh DM; Zweckstetter M; Walter J
    EMBO J; 2011 Jun; 30(11):2255-65. PubMed ID: 21527912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.
    Watts JC; Condello C; Stöhr J; Oehler A; Lee J; DeArmond SJ; Lannfelt L; Ingelsson M; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10323-8. PubMed ID: 24982139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.